GlaxoSmithKline’s alli is the only FDA- and EMEA-approved over-the-counter weight-loss aid, and will be introduced to the Greek market in November 2009.
Within the framework of the agreement, V+O will handle alli’s press office, media relations, as well as informational activities for journalists and pharmacists.
